Chen-Yu Wang (Chenyu Wang)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 14

Top Topics

Left Atrial Appendage

Venous Thromboembolism

Small Cell Lung Cancer

Oral Anticoagulants

Top Venues

Expert review of clinical pharmacology

Pharmaceuticals (Basel, Switzerland)

Acta pharmacologica Sinica

This page only lists publications with an associated author ORCID identifier.

Publications

Chen-Yu Wang, Hao-Ran Dai, Yu-Ping Tan, Di-Hong Yang, Xiao-Min Niu, Lu Han, Wen Wang, Ling-Ling Ma, Aleksi Julku, Zheng Jiao
Development and Evaluation of a Quantitative Systems Pharmacology Model for Mechanism Interpretation and Efficacy Prediction of Atezolizumab in Combination with Carboplatin and Nab-Paclitaxel in Patients with Non-Small-Cell Lung Cancer. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Chen-Yu Wang, Hao-Ran Dai, Yu-Ping Tan, Di-Hong Yang, Xiao-Min Niu, Lu Han, Wen Wang, Ling-Ling Ma, Aleksi Julku, Zheng Jiao
Development and Evaluation of a Quantitative Systems Pharmacology Model for Mechanism Interpretation and Efficacy Prediction of Atezolizumab in Combination with Carboplatin and Nab-Paclitaxel in Patients with Non-Small-Cell Lung Cancer. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Hao-Ran Dai, Yang Yang, Chen-Yu Wang, Yue-Ting Chen, Yi-Fan Cui, Pei-Jing Li, Jia Chen, Chen Yang, Zheng Jiao
Trilaciclib dosage in Chinese patients with extensive-stage small cell lung cancer: a pooled pharmacometrics analysis. Acta pharmacologica Sinica (2024)
Jinmeng Li, Xin-Jun Cai, Yue-Ting Chen, Chen-Yu Wang, Zheng Jiao
Parametric population pharmacokinetics of isoniazid: a systematic review. Expert review of clinical pharmacology (2023)
Jinmeng Li, Xin-Jun Cai, Yue-Ting Chen, Chen-Yu Wang, Zheng Jiao
Parametric population pharmacokinetics of isoniazid: a systematic review. Expert review of clinical pharmacology (2023)
Yue-Ting Chen, Yang Yang, Shansen Xu, Chen-Yu Wang, Pan Shu, Xiaoyu Zhang, Qin Huang, Jin Sook Kim, Zheng Jiao
Model Informed Development of SIM0295 in Patients with Gout and Hyperuricemia and Healthy Volunteers Using a Population Pharmacokinetics/ Pharmacodynamics Approach. Expert opinion on investigational drugs (2023)
Xiao-Qin Liu, Zi-Ran Li, Chen-Yu Wang, Yue-Ting Chen, Zheng Jiao
Is a Lower Dose of Rivaroxaban Required for Asians? A Systematic Review of a Population Pharmacokinetics and Pharmacodynamics Analysis of Rivaroxaban. Pharmaceutics 15 (2) (2023)
Xiao-Qin Liu, Zi-Ran Li, Chen-Yu Wang, Yue-Ting Chen, Zheng Jiao
Is a Lower Dose of Rivaroxaban Required for Asians? A Systematic Review of a Population Pharmacokinetics and Pharmacodynamics Analysis of Rivaroxaban. Pharmaceutics 15 (2) (2023)
Xiao-Qin Liu, Zi-Ran Li, Chen-Yu Wang, Yue-Ting Chen, Zheng Jiao
Is a Lower Dose of Rivaroxaban Required for Asians? A Systematic Review of a Population Pharmacokinetics and Pharmacodynamics Analysis of Rivaroxaban. Pharmaceutics 15 (2) (2023)
Xiao-Qin Liu, Zi-Ran Li, Chen-Yu Wang, Yue-Ting Chen, Zheng Jiao
Is a Lower Dose of Rivaroxaban Required for Asians? A Systematic Review of a Population Pharmacokinetics and Pharmacodynamics Analysis of Rivaroxaban. Pharmaceutics 15 (2) (2023)
Zi-Ran Li, Chen-Yu Wang, Wei-Wei Lin, Yue-Ting Chen, Xiao-Qin Liu, Zheng Jiao
Handling Delayed or Missed Dose of Antiseizure Medications: A Model-Informed Individual Remedial Dosing. Neurology (2022)
Yue-Ting Chen, Chen-Yu Wang, Yi-Wei Yin, Zi-Ran Li, Wei-Wei Lin, Min Zhu, Zheng Jiao
Population pharmacokinetics of oxcarbazepine: a systematic review. Expert review of clinical pharmacology 14 (7) (2021)
Xiao-Qin Liu, Wei-Wei Lin, Chen-Yu Wang, Zi-Ran Li, Xiao Zhu, Zheng Jiao
How to handle the delayed or missed dose of rivaroxaban in patients with non-valvular atrial fibrillation: model-informed remedial dosing. Expert review of clinical pharmacology 14 (9) (2021)
Lizhi Chen, Yunyun Yang, Xuebin Wang, Chen-Yu Wang, Weiwei Lin, Zheng Jiao, Zhuo Wang
Wuzhi Capsule Dosage Affects Tacrolimus Elimination in Adult Kidney Transplant Recipients, as Determined by a Population Pharmacokinetics Analysis. Pharmacogenomics and personalized medicine 14 (2021)